Slogan: Redefining Surgical Horizon
Description: Bluesail Surgical is a minimally invasive surgery division established by the leading A-share medical device company Bluesail Medical. The company has set up 4 R&D centers, 6 production sites, and 4 clinical trial registries globally, functioning as a 24-hour R&D system with 544 researchers and more than 300 patents. Their main products include Endoscopic Staplers, Open Staplers, Trocars, Hemostatic Forcep, and Ultrasonic Scalpel, among others. Leveraging Bluesail Medical’s expertise in R&D and sales channels, Bluesail Surgical aims to excel in medium and high-value surgical consumables, striving to offer surgeons a cost-effective, top-quality surgical equipment portfolio.
Founded: 2019
Industry: Biotechnology
Headquarter: China
Last Investment: CNY100.00M Series A investment at 21 May 2024
Last Investment Investors: Daxing Linkong Development Fund
For more information, visit bluesailsurgical.com/en/